panflu Stats

[Mixin]

01 Oct 2009 - Neopharma, the Abu Dhabi-based pharmaceuticals manufacturer, announced it has received clearance from the UAE Ministry of Health for the production of an antiviral medication Oseltamivir BR Flu. The approval comes at a time when the entire region is stepping up efforts to tackle the H1N1 pandemic. The drug is a potential choice to prevent and treat H1N1 flu in the region.

His Excellency Abdulla Humaid Al Mazroei, Vice-Chairman, Neopharma, and Dr.B.R. Shetty, Managing Director and CEO, thanked the UAE Ministry of Health on behalf of the Board of Directors of the company.

Dr. Shetty said: "The endorsement for the antiviral drug to be manufactured by Neopharma reflects the strong support of the Ministry of Health for the vision of the UAE leadership to create a self-sustaining community. As a leading manufacturer of life-saving drugs, we believe it is our responsibility to play a vital role in helping the community at this critical juncture.

Neopharma's Oseltamivir BR Flu is the outcome of a joint venture with Hetero Drugs Ltd and is the first in a series of major life-saving drugs the company plans to produce over the next few years.

http://www.bionity.com/news/e/107117/?WT.mc_id=ca0068
_________________
https://twitter.com/mixin1771